{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:20:08Z","timestamp":1763346008274,"version":"3.45.0"},"reference-count":32,"publisher":"Tech Science Press","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.066058","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T03:21:16Z","timestamp":1750821676000},"page":"3065-3076","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of Breast Cancer Cell Proliferation by 9-Hydroxycamptothecin-Loaded Zeolitic Imidazolate Nanoparticles"],"prefix":"10.32604","volume":"33","author":[{"given":"Chuansheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zirun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglai","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/1055-9965.EPI-20-1193","article-title":"Cancer progress and priorities: breast cancer","volume":"2021","author":"Houghton","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"783450","DOI":"10.3389\/fmolb.2022.783450","article-title":"Breast cancer; discovery of novel diagnostic biomarkers, drug resistance, and therapeutic implications","volume":"9","author":"Afzal","year":"2022","journal-title":"Front Mol Biosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-006-0357-8","article-title":"Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins","volume":"60","author":"Pawarode","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.bmc.2003.11.036","article-title":"Camptothecin: current perspectives","volume":"12","author":"Thomas","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2174\/0929867311320120006","article-title":"Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug","volume":"20","author":"Beretta","year":"2013","journal-title":"Curr Med Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5507\/bp.2019.010","article-title":"Nanodrugs used in cancer therapy","volume":"163","author":"Kopeckova","year":"2019","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2147\/IJN.S38378","article-title":"Nanodrugs: pharmacokinetics and safety","volume":"9","author":"Onoue","year":"2014","journal-title":"Int J Nanomed"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1166\/jnn.2014.9010","article-title":"Targeted nanodrugs for cancer therapy: prospects and challenges","volume":"14","author":"Bottini","year":"2014","journal-title":"J Nanosci Nanotechnol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"905375","DOI":"10.3389\/fphar.2022.905375","article-title":"Nucleus-targeting phototherapy nanodrugs for highly effective anti-cancer treatment","volume":"13","author":"Long","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"154669","DOI":"10.1016\/j.phymed.2023.154669","article-title":"Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B","volume":"111","author":"Yin","year":"2023","journal-title":"Phytomedicine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"174399","DOI":"10.1016\/j.ejphar.2021.174399","article-title":"Vorinostat targets UBE2C to reverse epithelial-mesenchymal transition and control cervical cancer growth through the ubiquitination pathway","volume":"908","author":"Pan","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","article-title":"Structures and mechanisms in the cGAS-STING innate immunity pathway","volume":"53","author":"Zhang","year":"2020","journal-title":"Immunity"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9798-5_1","article-title":"An overview of drug delivery systems","volume":"2059","author":"Jain","year":"2020","journal-title":"Methods Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.2174\/1871520618666180327140956","article-title":"A review on camptothecin analogs with promising cytotoxic profile","volume":"18","author":"Amin","year":"2018","journal-title":"Anticancer Agents Med Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1080\/14786419.2019.1665252","article-title":"Distribution of camptothecin biosynthetic intermediates and identification the rate-limiting step of camptothecin biosynthesis","volume":"35","author":"Sun","year":"2021","journal-title":"Nat Prod Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1021\/acsomega.7b01032","article-title":"Improved solubility and bioactivity of camptothecin family antitumor drugs with supramolecular encapsulation by water-soluble pillar[6]arene","volume":"2","author":"Liu","year":"2017","journal-title":"ACS Omega"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0928-0987(01)00214-7","article-title":"Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent","volume":"15","author":"Kang","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.028","article-title":"Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy","volume":"85","author":"Huang","year":"2019","journal-title":"Acta Biomater"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"217116","DOI":"10.1016\/j.canlet.2024.217116","article-title":"Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment","volume":"598","author":"Yang","year":"2024","journal-title":"Cancer Lett"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apsb.2020.09.016","article-title":"Recent advances in drug delivery systems for targeting cancer stem cells","volume":"11","author":"Duan","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/1389557053765547","article-title":"Synthesis and pharmacology of new camptothecin drugs","volume":"5","author":"Driver","year":"2005","journal-title":"Mini Rev Med Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2174\/138161208784246180","article-title":"Design, synthesis and development of novel camptothecin drugs","volume":"14","author":"Liew","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2217\/nnm-2019-0261","article-title":"Redox-sensitive dimeric camptothecin phosphatidylcholines-based liposomes for improved anticancer efficacy","volume":"2019","author":"He","year":"2019","journal-title":"Nanomed"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1208\/pt050340","article-title":"A method to determine the incorporation capacity of camptothecin in liposomes","volume":"5","author":"Saetern","year":"2004","journal-title":"AAPS PharmSciTech"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/2225-4110.110423","article-title":"Camptothecin-loaded liposomes with \u03b1-melanocyte-stimulating hormone enhance cytotoxicity toward and cellular uptake by melanomas: an application of nanomedicine on natural product","volume":"3","author":"Lin","year":"2013","journal-title":"J Tradit Complement Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.2967\/jnumed.114.146019","article-title":"Theranostic nanoparticles","volume":"55","author":"Chen","year":"2014","journal-title":"J Nucl Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/03639045.2016.1268151","article-title":"SN-38 loading capacity of hydrophobic polymer blend nanoparticles: formulation, optimization and efficacy evaluation","volume":"43","author":"Dimchevska","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1039\/D1TB02339J","article-title":"PDA-coated CPT@MIL-53(Fe)-based theranostic nanoplatform for pH-responsive and MRI-guided chemotherapy","volume":"10","author":"Zhou","year":"2022","journal-title":"J Mater Chem B"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"112365","DOI":"10.1016\/j.ejmech.2020.112365","article-title":"Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy","volume":"200","author":"Zhang","year":"2020","journal-title":"Eur J Med Chem"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-10\/OncolRes-33-10-66058\/OncolRes-33-66058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:16:17Z","timestamp":1763345777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n10\/63881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.066058","relation":{},"ISSN":["1555-3906"],"issn-type":[{"type":"electronic","value":"1555-3906"}],"subject":[],"published":{"date-parts":[[2025]]}}}